304 results

innovate2
Regulation

Posted on 25.06.2009

Achieving health improvements inside and outside the boardroom

A crowded room at the offices of the European Policy Center yesterday afternoon. The topic of the day is “The future of medical devices in Europe”. The distinguished panel includes Josée Hansen, Pharm. D, project leader, Priority Medical Devices/ EHT, WHO-Geneva . Ms Hansen elaborated on the project’s approach, scope and objectives. In a nutshell, […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

copenhagen
Value

Posted on 16.06.2009

Treating Osteoarthritis: will new research lead to a “run” of success?

On Thursday 11 June, I attended, as part of the EULAR conference in Copenhagen – Europe’s largest conference on Rheumatology – the session “Structure modification in osteoarthritis: Time to update the guidelines”. What became really apparent was that rheumatologists from Europe and North-America are seriously concerned about the exponentially increasing prevalence and incidence of osteoarthritis […]

By Rosanna Tarricone Director Master of International Health Care Management, Economics and Policy

hc-inno
Business

Posted on 29.05.2009

2009 Hauptstadtkongress debates affordability of innovation for the German healthcare system

Is innovation still affordable with increasingly strained healthcare budgets? How can medical innovations continued to be financed? Panelist of the round table of distinguished speakers Member of the European Parliament Jorgo Chatzimarkakis made a statement which nicely complements the study released by AdvaMed only 2 days ago. He said that innovation does not increase costs […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

berlin
Value

Posted on 29.05.2009

Is the German healthcare system setting the right incentives to provide the best patient care?

An exclusive roundtable hosted by Johnson & Johnson during this year’s Hauptstadtkongress debated the question whether the current healthcare system in Germany should compromise between the need to standardize treatments due to scarce resources and increasingly informed patients demanding the best treatment possible. Although panelists agreed that Germany may be leading in terms of standards […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

sustain
Value

Posted on 12.05.2009

Sustainabilty of European health systems

It takes very little to persuade me to visit Prague. It is one of the gems of Europe. On this occasion, though, I had little opportunity to enjoy the scenic beauty of the city as I arrived at 1.00 am and spent the day in an ornate, but windowless, ballroom in a classic early 20th […]

By John Wilkinson Former Chief Executive of Eucomed

collaboration
Global

Posted on 06.05.2009

MassMEDIC Annual Meeting: Reflections on industry clinician collaboration

Sitting on Boston’s south shore, the John F. Kennedy Pesidential Library is both imposing yet not over-stated. A rare treat for me was the opportunity to address the annual meeting of MassMEDIC, the largest regional medical technology association in the USA – and that means the world, I am sure! The speaker’s podium has a […]

By John Wilkinson Former Chief Executive of Eucomed

Press-release
Regulation Value

Posted on 10.04.2009

Eucomed press release 05/09 – Revised Directive on Late payments: 23.6 billion Euros of unpaid invoices threaten small companies’ survival and jeopardize public health

Brussels, 8 April 2009 – Eucomed welcomes revision of directive 2000/35/EC on Late Payments adopted by the European Commission today strengthening current payment obligations. Association disappointed to see final text considerably watered down compared to initial clear targets. As the voice of the medical technology industry in Europe, Eucomed is extremely pleased to see late […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed